Quality Assurance Sampling Plans in US Stockpiles for Personal Protective Equipment: A Computer Simulation to Examine Degradation Rates.


Journal

Health security
ISSN: 2326-5108
Titre abrégé: Health Secur
Pays: United States
ID NLM: 101654694

Informations de publication

Date de publication:
Historique:
entrez: 22 8 2019
pubmed: 23 8 2019
medline: 19 5 2020
Statut: ppublish

Résumé

Medical countermeasure stockpiles in the United States are designed to support healthcare workers and the public during public health emergencies; they include supplies of personal protective equipment (PPE). As part of typical PPE manufacturing processes, appropriate test methods are used to ensure that the devices provide adequate protective performance. At the time of manufacture, performance is often measured and weighed against an objective standard of quality, resulting in a pass or fail attribute being assigned to individual PPE items and thence to production lots. Incorporating periodic performance testing for stockpiled PPE can ensure that they maintain their protective qualities and integrity over time while in storage. There is an absence of guidance regarding how to design quality assurance programs for stockpiled PPE. The applicability of the Lot Quality Assurance Sampling (LQAS) approach to stockpiled PPE was examined in a previous study that compared and contrasted different sample sizes in recovering the true percentage of defective units in large lots in the LQAS framework. The current study carries this line of inquiry forward by integrating PPE degradation over time and comparing different sampling time intervals in recovering the true underlying degradation rate. The results suggest that product degradation is more easily detected when tested at shorter time intervals and for higher degradation rates. They further suggest that sampling interval groupings can be made based on the proficiency with which they recover the true underlying degradation rate.

Identifiants

pubmed: 31433277
doi: 10.1089/hs.2019.0042
pmc: PMC6823634
mid: NIHMS1054665
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

324-333

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Références

Clin Infect Dis. 2015 May 1;60 Suppl 1:S42-51
pubmed: 25878300
Am J Infect Control. 2009 Nov;37(9):703-7
pubmed: 19748157
Am J Infect Control. 2017 Mar 1;45(3):272-277
pubmed: 27916341
Health Secur. 2018 Mar/Apr;16(2):119-126
pubmed: 29570355
Acad Emerg Med. 2006 Nov;13(11):1198-203
pubmed: 16885400
J Int Soc Respir Prot. 2017;34(2):69-80
pubmed: 30364841
Disaster Manag Response. 2003 Jul-Sep;1(3):68-70
pubmed: 12888743
J Microsc. 2007 Jan;225(Pt 1):72-9
pubmed: 17286696
Infect Control Hosp Epidemiol. 2010 Oct;31(10):1011-6
pubmed: 20731598
Am J Public Health. 2018 Nov;108(11):1469-1472
pubmed: 30252525
Health Secur. 2019 Mar/Apr;17(2):140-151
pubmed: 31009257
Emerg Infect Dis. 2009 Jun;15(6):e1
pubmed: 21970033
BMC Public Health. 2015 Sep 03;15:847
pubmed: 26335570
Am J Infect Control. 2009 Jun;37(5):381-386
pubmed: 19188003

Auteurs

Mitchell T Dubaniewicz (MT)

Mitchell T. Dubaniewicz is a student researcher, Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, and was on assignment with CDC/NIOSH/NPPTL.

Dana R Rottach (DR)

Dana R. Rottach, PhD, is a Physical Scientist, and Patrick L. Yorio, PhD, is a Health Statistician; both at the National Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Pittsburgh, PA.

Patrick L Yorio (PL)

Dana R. Rottach, PhD, is a Physical Scientist, and Patrick L. Yorio, PhD, is a Health Statistician; both at the National Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Pittsburgh, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH